Inhibitory effect of chalcone derivatives on recombinant human aldose reductase

Biological and Pharmaceutical Bulletin

Volumn 22, Issue 3, 1999, Pages 323-325

  Iwata, Susumu ^a   Nagata, Nobuyuki ^a   Omae, Ayako ^b   Yamaguchi, Shino ^b   Okada, Yoshihito ^b   Shibata, Shoji ^c   Okuyama, Toru ^b  

^a Minophagen Pharmaceutical Co   (Japan)

^b MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

^c c/o Minophagen Pharmaceutical C ^*  (Japan)

Author keywords

Aldose reductase; Chalcone derivative; Isoliquiritigenin; Structure activity relationship

Indexed keywords

ALDEHYDE REDUCTASE; CHALCONE DERIVATIVE; ISOLIQUIRITIGENIN;

ARTICLE; CATARACT; CIS TRANS ISOMERISM; DIABETES MELLITUS; DIABETIC RETINOPATHY; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME ACTIVITY; KERATOPATHY; STRUCTURE ACTIVITY RELATION;

EID: 0032905879     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.22.323     Document Type: Article

References (25)

1. Part III of Search for Naturally Occurring Substances to Prevent the Complications of Diabetes.
2. Gasha M., Tsuji A., Kurumi M., Endo T., Sato S., Yamaguchi K., Yakugaku Zasshi, 92, 719-723 (1972).
3. Hsu K. K., Lin Y. C., Su C. T., Lien E. J., Taiwan Pharm. Assoc., 34, 71-86 (1982).
4. Kyougoku K., Hatoyama K., Yokomori S., Saziki R., Nakane S., Sasajima M., Sawada J., Ohzeki M., Tanaka I., Chem. Pharm. Bull., 27, 2943-2953 (1979).
5. Dimmock J. R., Kandepu N. M., Hetherington M., Quail J. W., Pugazhenthi U., Sudom A. M., Chamankhah M., Rose P., Pass E., Allen T. M., Halleran S., Szydlowski J., Mutus B., Tannous M., Manavathu E. K., Myers T. G., Clercq E. D., Balzarini J., J. Med. Chem., 41, 1014-1026 (1998).
6. Sogawa S., Nihro Y., Izumi A., Miki T., Matsumoto H., Satoh T., J. Med. Chem., 36, 3904-3909 (1993).
7. Lin C. N., Lee T. H., Hsu M. F., Wang J.P., Ko F. N., Teng C. M., J. Pharm. Pharmacol., 419, 530-536 (1997).
8. Iwata S., Nishino T., Nagata N., Satomi Y., Nishino H., Shibata S., Biol. Pharm. Bull., 18, 1710-1713 (1995).
9. Iwata S., Nishino T., Inoue H., Nagata N., Satomi Y., Nishino H., Shibata S., Biol. Pharm. Bull., 20, 1266-1270 (1997).
10. Tanaka S., Kuwai Y., Tabata M., Planta Med., 53, 5-8 (1987).
11. Kusano A., Nikaido T., Kuge T., Ohmoto T., Monache G. D., Botta B., Botta M., Saitoh T., Chem. Pharm. Bull., 39, 930-933 (1991).
12. Yamamoto S., Aizu E., Jiang H., Nakadate T., Kiyoto I., Wang J. C., Kato R., Carcinogenesis, 12, 317-323 (1991).
13. Aida K., Tawata M., Shindo H., Sasaki H., Yamaguchi T., Chin M., Mitsuhashi H., Planta Med., 57, 254-258 (1990).
14. Varma S. D., Kinoshita J. H., Biochem. Pharmacol., 25, 2505-2513 (1976).
15. Okuda J., Miwa I., Inagaki K., Horie T., Nakayama M., Biochem. Pharmacol., 31, 3807-3822 (1982).
16. Chaudhrt P. S., Cabrera J., Juliani H. R., Varma S. D., Biochem. Pharmacol., 32, 1995-1998 (1983).
17. Okuda J., Miwa I., Inagaki K., Horie T., Nakayama M., Chem. Pharm. Bull., 32, 767-772 (1984).
18. Part I of this series; Okada Y., Miyauchi N., Suzuki K., Kobayashi T., Tsutsui C., Mayuzumi K., Okuyama T., Nat. Med., 48, 324-329 (1994).
19. Part II of this series; Okada Y., Miyauchi N., Suzuki K., Kobayashi T., Tsutsui C., Mayuzumi K., Nishibe S., Okuyama T., Chem. Pharm. Bull., 43, 1385-1387 (1995).
20. Hano Y., Suzuki S., Nomura T., Ueda S., Heterocycles, 29, 807-813 (1989).
21. Oganesyan E. T., Yakovenko V. I., Khachatryan M. M., Pershkov S. R., Cherevatyi V. S., Khim-Farm Zh. 20, 696-702 (1986).
22. Mishra S., Rao J. T., J. Inst. Chem., 61, 181-182 (1995).
23. Anto R. J., Sukumaran K., Kuttan G., Rao M. N. A., SubbaraJu V., Kurtan R., Cancer Lett., 97, 33-37 (1995).
24. Wolff S. P., Crabbe M. J. C., Biochem. J., 226, 625-630 (1985).
25. Thornalley P. J., Wolff S. P., Crabbe M. J. C., Stern A., Biochim. Biophys. Acta, 797, 276-287 (1984).